ArticleJournal of the Society for Cardiovascular Angiography & Interventions
Intravascular Lithotripsy for Peripheral Artery Calcification: Mid-term Outcomes From the Randomized Disrupt PAD III Trial.
Article in Journal of the Society for Cardiovascular Angiography & Interventions. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- Long-term outcomes of the "pave-and-crack" technique for severely calcified femoropopliteal chronic total occlusions.CVIR endovascular · 2026Article
- Feasibility and Early Results of Peripheral Intravascular Lithotripsy in Heavily Calcified Femoropopliteal Disease: Single-Center Experience.Acta Cardiologica Sinica · 2026Article
- Pulsatile Intravascular Lithotripsy for Heavily Calcified Femoropopliteal Arterial Disease: First-in-Human Results from the POWER PAD I Feasibility Study.Journal of clinical medicine · 2026Article
- Transformative Advances in Vascular Surgery: Five Decades of Innovation in the Management of Aortic, Carotid, and Peripheral Arterial Disease.World journal of surgery · 2026Review
- Device design and applications of the novel JAVELIN peripheral intravascular lithotripsy catheter.Journal of vascular surgery cases and innovative techniques · 2026Article
- Study Protocol for the Evaluation of Morphologic and Imaging Remodeling of Atherosclerotic Plaque Following Intravascular Lithotripsy in Peripheral Artery Disease.Journal of clinical medicine · 2026Article
- Intravascular lithotripsy of the femoropopliteal arteries: analysis of a prospective two-center pilot study.Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2026Article
- First Report of Intentional Intraplaque Lithotripsy After Aggressive Wire Recanalization in Calcified Atheroma and Dilatation (ARCADIA-SHOCK).Journal of the Society for Cardiovascular Angiography & Interventions · 2026Article
- Bailout Intravascular Lithotripsy for Calcium-Mediated Underexpansion of a Peripheral Covered Stent in an Emergency Setting: A Case Report.Case reports in surgery · 2026Article
- Challenging the No-Stent Zone: Intravascular Lithotripsy for Common Femoral Artery Disease.Journal of clinical medicine · 2025Review
- Shockwave Versus Surgical Endarterectomy for Calcified Severe Common Femoral Artery Stenosis: Design and Rationale of the SHOCKIFY Trial.Journal of the Society for Cardiovascular Angiography & Interventions · 2025Article
- Shocking safely: Intravascular lithotripsy to under expanded interwoven stent.Journal of vascular surgery cases and innovative techniques · 2025Article
- Novel Interventions to Improve Adherence to Guideline-Directed Medical Therapy in Claudicants.Journal of clinical medicine · 2025Review
- [AVK III: Below the knee].Innere Medizin (Heidelberg, Germany) · 2025Review
- Overview of Therapeutic Ultrasound Applications and Safety Considerations: 2024 Update.Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine · 2025Review
- Off-label use of intravascular lithotripsy in severely calcified carotid stenosis: a case series and literature review.AME case reports · 2025Article
- Calcium Challenge - Tackling Rings, Nodules and Plates: How Can We Get More from Intravascular Lithotripsy Technology?Interventional cardiology (London, England) · 2025Review
- Comparison of Endovascular Interventions for the Treatment of Superficial Femoral Artery Disease: A Network Meta-analysis.Journal of the Society for Cardiovascular Angiography & Interventions · 2025Review
- Analysis of factors influencing health-related quality of life in patients with femoropopliteal atherosclerotic occlusive disease treated with drug-coated balloons 12 months after surgery.Frontiers in surgery · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Endovascular treatment of calcified peripheral artery lesions may be associated with suboptimal vessel expansion, increased complication risk, and reduced long-term patency. The primary endpoint from the Disrupt PAD III randomized controlled trial (RCT) demonstrated superior procedural success in patients treated with intravascular lithotripsy (IVL) vs percutaneous transluminal angioplasty (PTA). The present study evaluates primary patency after 1 and 2 years in this randomized population. Methods: The Disrupt PAD III RCT enrolled 306 patients with moderately-to-severely calcified femoropopliteal arteries treated with IVL ( Results: Primary patency at 1 year was significantly greater in the IVL arm (80.5% vs 68.0%, Conclusions: The Disrupt PAD III RCT secondary endpoint of superior 1-year primary patency was achieved, confirming the consistent safety and effectiveness of IVL followed by DCB treatment to facilitate a durable approach for patients with heavily calcified femoropopliteal arteries largely without stent requirement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.